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Background. Gene expression profiling and the analysis of protein-protein interaction (PPI) networks may support the
identification of disease bio-markers and potential drug targets. Thus, a step forward in the development of systems
approaches to medicine is the integrative analysis of these data sources in specific pathological conditions. We report such an
integrative bioinformatics analysis in human heart failure (HF). A global PPI network in HF was assembled, which by itself
represents a useful compendium of the current status of human HF-relevant interactions. This provided the basis for the
analysis of interaction connectivity patterns in relation to a HF gene expression data set. Results. Relationships between the
significance of the differentiation of gene expression and connectivity degrees in the PPI network were established. In
addition, relationships between gene co-expression and PPI network connectivity were analysed. Highly-connected proteins
are not necessarily encoded by genes significantly differentially expressed. Genes that are not significantly differentially
expressed may encode proteins that exhibit diverse network connectivity patterns. Furthermore, genes that were not defined
as significantly differentially expressed may encode proteins with many interacting partners. Genes encoding network hubs
may exhibit weak co-expression with the genes encoding their interacting protein partners. We also found that hubs and
superhubs display a significant diversity of co-expression patterns in comparison to peripheral nodes. Gene Ontology (GO)
analysis established that highly-connected proteins are likely to be engaged in higher level GO biological process terms, while
low-connectivity proteins tend to be engaged in more specific disease-related processes. Conclusion. This investigation
supports the hypothesis that the integrative analysis of differential gene expression and PPI network analysis may facilitate a
better understanding of functional roles and the identification of potential drug targets in human heart failure.
Citation: Camargo A, Azuaje F (2007) Linking Gene Expression and Functional Network Data in Human Heart Failure. PLoS ONE 2(12): e1347.
doi:10.1371/journal.pone.0001347
INTRODUCTION
Heart failure (HF) stems from complex genetic, environmental and
life style factors and is one of the main causes of death in the world
[1]. Myocardial infarction, ischemic cardiomyopathy and dilated
cardiomyopathy (DCM) may contribute to the emergence of HF.
The latter, is a leading cause of congestive heart failure [1,2]. In
DCM, the heart becomes enlarged, which makes the pumping of
blood less efficient to vital organs. Due to the high rate of
morbidity and mortality attributed to HF, previous studies have
aimed to unveil the genetic factors crucial to the emergence and
development of the disease. As a result, HF signature genes [3,4,5],
protein-protein interactions (PPI) and larger gene expression data
sets have been made publicly available [6]. Thus, it has been
suggested that the integration of these sources may improve the
identification of clinically-relevant disease markers [6,7].
Recent examples of the predictive power of integrative
bioinformatics approaches to investigating diseases have been
reported by Oti et al. (2006) [8] and Xu and Li (2006) [9]. They
investigated whether signature genes of genetically heterogeneous
and hereditary diseases could be predicted from the analysis of PPI
networks. Lu et al. (2007) [10] integrated gene expression analysis
and a biological interaction network to investigate the allergic
response in asthma. Cline et al. (2007) [11] proposed a generic
protocol to integrate gene expression data and biological networks,
which may help to explain the control mechanisms underlying the
observed changes in activity of a biological process. In the context
of HF, Barth et al. (2006) [2] analysed gene expression patterns
related to DCM and identified specific gene regulatory relation-
ships. Here, using a DCM-related microarray data set, we report
an analysis of human HF gene expression responses in relation to a
HF-specific PPI network.
To build the HF PPI network, known HF-relevant genes
(KHFG) were first identified together with validated PPIs of their
encoded proteins according to the Human Protein Reference
Database (HPRD) [12]. This was followed by the identification of
differentially expressed genes from microarray data encoding
molecular profiles of healthy vs. HF subjects. The proteins
encoded by these significantly differentially-expressed genes were
mapped onto the global HF PPI network. We first assessed key
statistical and topological relationships between significantly
differentially-expressed genes and the interaction network. Results
showed that in terms of gene expression, genes significantly
differentially expressed are not always represented by highly-
connected nodes. Other results showed that, although not
significantly differentially-regulated, some of the proteins encoded
by genes traditionally associated with HF may interact with
proteins encoded by significantly differentially-expressed genes,
and that the latter tend to be highly connected. Further analyses,
which integrated expression data and the PPI network, evaluated
levels of co-expression between genes encoding network nodes and
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PLoS ONE | www.plosone.org 1 December 2007 | Issue 12 | e1347corresponding genes encoding their interacting partners. A key
question was whether there was any significant quantitative
relation between co-expression levels and network connectivity
degree. This analysis indicate that: a) genes represented by
network hubs may exhibit weak co-expression with the genes
encoding their interacting protein partners; and b) genes that were
not defined as significantly differentially-expressed in the gene
expression data analysis may encode proteins with many
interacting partners. These significant findings were replicated
using a second, independent microarray data set. To identify
biological process overrepresentations associated with the PPI
network’s topology, the data were analysed in the context of the
Gene Ontology. Results show that genes represented by highly-
connected nodes are more likely to be engaged in higher-level
biological process terms (as defined by the Gene Ontology), than
genes represented by low-connectivity nodes. This study supports
the idea that a PPI network integrated with expression data may
further assist researchers in identifying potential disease markers or
therapeutic targets, which might be overlooked when results rely
on expression profiling analyses only.
RESULTS
This study evaluated human HF gene expression responses, in
relation to the topology of a HF-specific PPI network. The
microarray data set analysed was obtained from the Gene
Expression Omnibus (GEO) [13], accession number GDS2206.
This data set, which was derived from a study on DCM, consisted
of 28 samples: 15 and 13 samples obtained from non-failing hearts
and HF patients respectively. After pre-processing, significantly
differentially-expressed genes were identified by performing
significance analysis of microarray (SAM) [14]. To validate
significant findings, a second microarray data set was used. This
second data set, also derived from a study on DCM, was obtained
from the GEO, accession number GDS2206, and included 12
samples: 5 samples originated from non-failing hearts and 7
samples from HF patients (see Methods).
The PPI network was assembled by including validated
interactions, as reported in the HPRD [12], for KHFGs and for
proteins encoded by genes included in the expression data sets. For
the network visualisation, a colour labelling scheme was used to
distinguish between the types of proteins each node represented.
In addition, nodes were classified according to the degree of
connectivity. Superhubs were represented by nodes with connec-
tivity degree greater than 100, hubs referred to nodes with
connectivity degree greater than 20 and lower than 100,
peripheral-A were nodes with connectivity greater than two and
lower than 20; and peripheral-B nodes represented proteins with
one interacting partner (see Methods).
To evaluate relationships between connectivity and significantly
differentially-expressed expression patterns, topological analysis of
the network was carried out. Furthermore, network topology was
integrated with the DCM expression data to evaluate gene
connectivity versus co-expression levels. To calculate co-expression
levels linked to every node in the network, the nodes and their
interaction partners were mapped into the DCM expression data
set. Next, Pearson’s correlation coefficients between the expression
profile of each gene coding for a node and each gene coding for its
interaction partners were calculated. Correlation value pairs were
regarded as significantly co-expressed if P-value,0.01. Finally, the
co-expression level of a gene was calculated by comparing the
number of its significantly co-expressed interactions against the
total number of its interacting proteins (see Methods). The PPI
network was analysed in the context of Gene Ontology (GO) to
identify biological process overrepresentations. Over-represented
biological processes were ranked according to their position in the
GO hierarchical scheme [15] (see Methods).
Network analysis
The PPI network (Figure 1A) consisted of nodes representing
proteins and their interaction partners. Some of the nodes
represented proteins encoded by significantly differentially-
expressed genes obtained from expression pattern analysis.
Initially, 1161 genes were identified (974 up-regulated in DCM
and 187 down-regulated in DCM). However, only 506 (457 up-
regulated and 49 down-regulated genes) were represented in the
network because their encoded proteins were reported to have at
least one interacting protein partner. The network also contained
71 nodes representing proteins encoded by KHFGs only. The
network contained 2835 nodes representing proteins encoded by
not significantly differentially-expressed genes (Table 1).
According to the node hierarchy described in Methods, 2.3% of
the genes were represented by network hubs or superhubs
corresponding to 47 significantly differentially-expressed genes (4
superhubs and 43 hubs). In contrast, 97.0% of the genes were
represented by either network peripheral-A or peripheral–B nodes
corresponding to 459 significantly differentially-expressed genes (279
peripheral-A and 180 peripheral-B). Details are shown in Table 1.
Three statistical significance tests based on random sampling were
implemented to allow us to reject the null hypothesis that the
proportion of significantly differentially-expressed genes (which were
also categorised as either hubs or superhubs) was obtained by
chance. These tests are described in Methods. All the statistical
significance tests reported P=0. Thus, this supports the conclusion
that the observed proportions are statistically significant, i.e. larger
than the proportions expected by chance.
Examples of potentially relevant associations are described as
follows. BCAR1 is a protein represented by a network superhub
(Figure 1B) and NAP1L1 is represented by a peripheral-B.
According to the gene expression analysis, both BCAR1 and
NAP1L1 encoded significantly differentially-expressed genes. AKT1
also represents a network superhub (Figure 1C). The gene
encoding AKT1 is known to be associated with HF and it is
involved in several functional processes relevant to the develop-
ment of this disease, such as Apoptosis and the MAPK (Mitogen-
activated protein kinase) signalling pathway [16].
Only 40, out 71, KHFGs had a corresponding transcript in the
DCM data set, and only one of these genes, SOD1, was
significantly differentially-expressed. Moreover, 2051 genes that
encoded other protein’s interaction partners in the network had a
corresponding transcript in the gene expression data set and were
not significantly differentially-expressed. There were KHFGs with
no corresponding transcripts in the DCM data set because these
were either included in the array but with significant missing
values across the experimental samples, or their probes were not
included in the array.
Network connectivity versus significant gene
expression patterns
This section of the study integrated gene expression data with the
PPI network to describe potential significant relationships between
network connectivity and gene expression patterns (as described in
Methods). The first set of results, involving significantly differen-
tially- expressed genes, found that genes represented by network
superhubs and hubs tend to have lower range of ‘di’s values (the
score of class differentiation). In Figure 2 genes with those
characteristics are shown on the farthest right side of the plot. On
the contrary, genes represented by network peripherals-A and -B
Integrative Bioinformatics
PLoS ONE | www.plosone.org 2 December 2007 | Issue 12 | e1347Figure 1. PPIs networks. PPIs networks corresponding to (A) global human HF network, (B) BCAR1’s PPI network, (C) AKT1’s PPI network. All PPIs were
retrieved from the HPRD. Up-regulated genes are represented by red nodes. Down-regulated genes are represented by green nodes. Known HF
genes (KHFG) are represented by nodes in yellow. Other genes encoding interacting partner proteins are represented by nodes in purple, if they have
a corresponding transcript, or in grey if they have no corresponding transcripts in the gene expression data set.
doi:10.1371/journal.pone.0001347.g001
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non-significantly differentially-expressed genes were assessed, we
found that some of these protein’s interacting partners were encoded
by several significantly differentially-expressed genes. For instance,
GRB2 has 180 interacting partners and was not found to be
significantly differentially-expressed in the gene expression data.
However,19genesencodingitsinteractingpartners,suchasABL1or
BCAR1, were identified as significantly differentially-expressed in the
expression data analysis. We analysed the biological role of GRB2,
and its corresponding interacting partners, and found that processes
such as ‘signal transduction’, ‘‘regulation T Cell activation’’ or
‘‘regulation of MAPK activity’’ were over-represented (P,0.0001).
According to KEGG and Reactome, GRB2 is involved in more than
15 pathways. Other proteins whose interacting partners were
encoded by more than 15 significantly differentially-expressed genes
were TP53, NR3C1, SMAD2, CASP3, ESR1, RB1 and YWHAG
(Annex S1 shows complete list), which are involved in functional
processes such as apoptosis or cell cycle. These findings stress the
importance of performing gene expression analysis in conjunction
with interaction networks to help to identify otherwise overlooked
potential clinically-relevant targets.
Gene co-expression analyses in the context of
network connectivity
In this section gene expression data were integrated with the
topology of the PPI network to assess significant co-expression levels
(as detailed in Methods). We found that genes represented by
network hubs and superhubs are not necessarily significantly co-
expressed with their attributed protein-coding partners (IPs), than
other types of nodes. For example, genes MAPK1 and FXR2,
represented by network superhubs, were significantly co-expressed
with 15.5% and 10.2% of the genes encoding their IPs
respectively. On the other hand, genes represented by network
peripheral-A and -B may be strongly correlated with their
interacting partners. For example, ALDOB, represented by a
network peripheral-A, was significantly co-expressed with all the
genes encoding its IPs (i.e. 100% significant co-expression level).
Table 2 shows more details of the difference between these
categories in terms of mean cL values. No statistical significance
difference between category means were found at P=0.05.
However, note that only network peripherals-A or –B showed
cases with cL=100%. The global trend, as shown in Figure 3, is
that the higher the number of node connections the greater the
tendency to display low cL values. Figure 3A shows a scatter plot of
the number interacting partners (IPi) for a gene i, versus its
significant co-expression level (cLi) (as defined in Methods). Similar
trend was observed when non-significantly differentially expressed
genes were analysed. For example, HAP1 and SIN3A, represented
by network peripherals-A, were significantly co-expressed with all
their partners, IPs. Figure 3B plots (IPi) versus (cLi) of non-
significantly differentially-expressed genes. When analysing nodes
representing KHFGs, results showed that in general cLi of these
Table 1. Summary of nodes population according to
connectivity.
......................................................................
Hierarchy SEg KHFG N-SEg Total %
Superhub 4 3 0 0.21
Hub 43 24 5 2.11
Peripheral-A 279 37 585 26.41
Peripheral-B 180 7 2245 71.28
Total 506 71 2835 3412
Summary of nodes population according to connectivity. % nodes within each
category present in the interaction network. Significantly differentially-
expressed genes (SEg). Non-significantly differentially-expressed genes (N-SEg).
Known HF genes (NHFG).
doi:10.1371/journal.pone.0001347.t001
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Figure 2. Plot of t-statistics (cL). Plot of t-statistic (di) representing the score for gene i vs. number of interacting partners (IP Log2) associated with
protein encoded by gene i.
doi:10.1371/journal.pone.0001347.g002
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PLoS ONE | www.plosone.org 4 December 2007 | Issue 12 | e1347genes was low. In fact, none of the 40 KHFGs, which had a
corresponding transcript in the DCM expression data, obtained a
cLi.50% (Figure 3C). For example, the cLi for PRKCA,
represented by a network superhub, was equal to 16.2% (i.e. this
gene’s expression pattern was significantly co-expressed with only
a few of the genes coding for its IPs).
In order to estimate the potential biological relevance of the
significant relationships found, as well as their reproducibility, these
pattern association procedures were replicated on a second,
independent human HF gene expression data set. Figure 3D, which
reviews the overall results of this second analysis, corroborates the
findings presented above. Genes encoding network hubs and
superhubs tend to be more weakly co-expressed with the genes
coding for their network interacting partners (IPi) than those genes
represented by network peripherals-A and –B. For example, cLi of
genes encoding network superhubs and hubs, such as AR, MAPK1,
PTPN11 or RAF1, were lower than 5%. On the contrary, the cLi of
MRFAP1L1, encoding a network peripheral-A, was equal to 100%.
The final analysis of this sequence evaluated the variation of co-
expression levels (cLs) across the four categories of network nodes.
Gene’s cL values were grouped according to node category and the
significance of the variance among these categories was estimated by
F-statistics. Results indicated (Table 3) that there are significant
differences between high connectivity categories (hubs and super-
hubs) and low connectivity categories (peripherals-A and –B)
(F=10.93, P,0.000001). By contrast, F-statistics found no significant
difference when comparing high connectivity categories (network
hubs vs. superhubs) (F=4.53,P=0.14). Further, analysis of variance
(ANOVA) among all four categories was performed, from which no
significant differences were found (F=0.93,P=0.42). This analysis
suggests that hubs and superhubs display a significant diversity of co-
expression patterns in comparison to peripheral nodes.
Genes were ranked according to their co-expression levels (cL),
such that a gene, i, was defined as low co-expressed if its cLi was below
0.80 and highly co-expressed if its cLi was greater or equal than 0.80.
For example, MAPK1’s cL is equal to 0.15, therefore the gene was
labelled as low co-expressed. An example of a highly co-expressed
gene is ALDOB, whose cL is equal to 1.0 (100% significant co-
expression). Once the genes were grouped according to this
criterion, F-statistics were applied to estimate variability between
Figure 3. Scatter plot of the number interacting partners (IPi) for a gene i, versus its significant co-expression level (cLi). (A) significantly
differentially-expressed genes. (B) Non-significantly differentially-expressed genes. (C) KHFGs. (D) Independent testing data set.
doi:10.1371/journal.pone.0001347.g003
Table 2. Summary of average co-expression levels (cL) for
each network node category.
......................................................................
Categories Average cL 6 SD
Superhubs 17.33 6 4.59
Hubs 15.45 6 10.39
Peripherals-A 16.51 6 26.65
Peripherals-B 14.48 6 35.21
Summary of average co-expression levels (cL) for each network node category.
SD: Standard deviation. No statistical significant difference between category
means were found at P=0.05.
doi:10.1371/journal.pone.0001347.t002
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PLoS ONE | www.plosone.org 5 December 2007 | Issue 12 | e1347significant co-expression levels of these two groups. We found that
the difference of significant co-expression levels between these two
groups was statistically significant (F=103.97, P,0.00001).
Through this analysis, we found that the cLs of MAP3K5 and
PABPC1 (represented by network peripherals-B) were of 0.80 and
0.87 respectively. Watanabe and Otsu (2004) [17] reported that
MAP3K5 promotes heart dysfunction and dilation, as well as
cardiac fibrosis. A previous study by Deo et al. (2002) [18] linked
PABPC1 to SOD1, the latter was the only KHFG significantly
differentially-expressed in our expression analysis.
GO analysis
ThePPInetworktopologywasalsoassessed inthecontextoftheGO
to identify major biological roles within each node category. Genes
represented by network peripherals-A tend to be involved in a
greater number of lower-level GO biological processes (e.g. ‘‘CD4-
positive, alpha-beta T cell differentiation during immune response’’,
‘‘G1/S transition of mitotic cell cycle’’, ‘‘insulin-like growth factor
receptor signalling pathway’’) than those represented by network
hubs and peripherals-B (Table 4). The ‘‘G1/S transition of mitotic
cell cycle’’ biological process has been reported to be fundamental in
the development of HF [3]. Table 4 also shows that genes
represented by network superhubs tend to be involved in a greater
number of higher-level biological processes (e.g. ‘‘cell communica-
tion’’ or ‘‘signal transduction’’). These results are consistent with
results obtained by Lu et al. (2007) [10] in an asthma model.
However, we also demonstrated that genes represented by network
peripherals-B tend to perform higher-level biological processes
(Annex S2 contains complete list of over-represented GO biological
processes). But the latter may be explained by the relative lack of
experimental studies of these genes.
This analysis also corroborates that some genes found to be not
significantly differentially-expressed may influence the activation or
repression of several other gene products. For example, the protein
encoded by NR3C1 gene is known to interact with 82 proteins. GO
analysisofNR3C1,andcorrespondinginteractingpartners,identified
more than 60 significantly over-represented biological processes.
Examples of such relevant functional categories are ‘‘transcription’’
or ‘‘transcription from RNA polymerase II promoter’’ (P,0.00001).
This gene was not significantly differentially-expressed, but its
encoded protein interacts with 17 proteins encoded by genes that
were significantly differentially-expressed in the expression data
analysis (e.g. HNRPU, MAPK1, PRPF6, RAF1, NFKB1 and STAT3).
These genes are known to be involved in crucial processes relating to
cardiac remodelling, such as apoptosis, MAPK signalling pathway or
immune system signalling as described in KEGG and Reactome
databases and by other authors [3,16,19]. In addition, Kang and
Izumo(2000) [16] suggested thatDCMisa oneofthemostcommon
forms of HF associated with apoptosis pathways dysfunction.
DISCUSSION
Undoubtedly gene expression pattern analyses have provided
insights into the biological basis of several deadly diseases. Because
of this, an important question is how to take advantage of available
public data and information bases. Moreover, there are concerns
about the reproducibility of functional predictions and pattern
identification results obtained using different data sets and platforms.
In human heart failure, a fair amount of microarray expression
data have been produced and uploaded into public databases.
Moreover, a number of disease signature genes have been
reported [2,3,7]. The challenge now is to find ways to integrate
such information in order to facilitate the discovery of disease-
specific knowledge and targets, as well as their reproducibility
using different data sources. This study evaluated gene expression
responses from the perspective of a PPI network and several
external functional information sources. Quantitative analysis
approaches were applied to elucidate significant global patterns
and trends encoded in these data sources. In particular, we address
the following questions: a) how network-based targets relate to
significantly differentially (or not differentially) gene expression-
based targets; and b) how network connectivity relates to
significant levels of co-expression between interacting partners.
To answer these questions a PPI network based on proteins
encoding KHFGs and other expressed genes was built. Significant
quantitative relationships between gene expression data and the
PPI network were identified. Such relationships and relevant
functional patterns may allow one to identify significant genes and
specific biological processes, which may be overlooked when
analyses rely on gene expression data only. Furthermore,
significant quantitative relationships were reproduced using an
independent data set.
The integration of expression data and the PPI network allowed
us to identify functionally-important, influential genes, which were
not found to be significantly differentially expressed in the
expression data analysis. Some of the proteins encoded by these
genes were reported to influence relatively large sets of proteins,
which may be encoded by significantly differentially-expressed
genes. For instance, proteins encoded by genes SMAD2, CASP3,
ESR1 and RB1, interacted with 17, 16, 16 and 15 proteins encoded
by significantly differentially-expressed genes. In the case of
KHFGs, nearly 50% of them had no corresponding transcripts
in the DCM data sets. However, the proteins they encoded were
reported to interact with several others proteins, which were
encoded by significantly differentially-expressed genes. For
example, the protein encoded by STAT3 (represented by a
Table 3. Analysis of variance of co-expression levels (cL) across
categories of network nodes.
......................................................................
Categories compared F-value P-value
Hubs vs. superhubs 4.53 0.14
Hub vs. peripheral-A 7.41 0
Hub vs. peripheral-B 12.99 0
Superhub vs. peripheral-A 33.66 0.003
Superhub vs. peripheral-B 58.92 0.001
Peripheral-A vs. peripheral-B 1.75 0
Superhub, Hub vs. peripheral-A,-B 10.93 0
ANOVA (between all categories) 0.93 0.42
Analysis of variance of co-expression levels (cL) across categories of network
nodes. Significance level from F-statistics is represented in the form of P-values.
doi:10.1371/journal.pone.0001347.t003
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Table 4. GO analysis, significantly over-represented biological
processes.
......................................................................
Category % higher-level GO terms % lower-level GO terms
Superhub 0.29 0.71
Hub 0.15 0.85
Peripheral-A 0.06 0.94
Peripheral-B 0.15 0.85
Significance level ,0.05.
doi:10.1371/journal.pone.0001347.t004
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PLoS ONE | www.plosone.org 6 December 2007 | Issue 12 | e1347network hub) was reported to interact with other 94 proteins.
Among them, nine were encoded by significantly differentially-
expressed genes, such as MAPK1 or PDIA3, which are involved in
functional pathways such as natural killer cell mediated cytotox-
icity or MAPK signalling. These pathways are involved in the
aetiology of HF [3]. In addition, evidence based on published
papers has demonstrated the involvement of STAT3 in the
protection of the myocardium from HF [20,21].
The integrative analysis of gene expression data and the PPI
network suggests that proteins represented by network peripherals-
A and -B tend to be encoded by genes that are significantly co-
expressed with most of the genes encoding their interacting
proteins. This relationship was not observed in the case of network
hubs and superhubs. In terms of biological significance, these
analyses also showed that genes encoding network superhubs and
hubs tend to be involved in higher-level biological processes as
defined by the GO Biological Process hierarchy. Furthermore,
genes represented by network peripherals-A tend to be associated
with lower-level biological processes.
The integrative study reported here highlights three important
aspects. First, the approaches implemented may help to identify
potentially influential genes (e.g. STAT3, TGFB1, AKT1, SIN3A,
PABPC1, MAP3K5), otherwise overlooked by single-source expres-
sion pattern analysis. Second, it also represents a powerful
methodology to trace biological processes that may outline
potential clinical biomarkers or therapeutic targets and their
corresponding interacting partners. Third, in combination with
expression data this approach can be used as a tool to evaluate
stimulus/response studies. For example, two microarray data sets
can be mapped onto an interaction network to analyse gene
repression or activation when different experimental conditions
are studied. The latter application will be reported as part of a
forthcoming study.
Despite the fact that the global human HF network presented
here is far from complete and that it may include false positive
interactions, biologically-significant quantitative and qualitative
relations were identified. Moreover, significant quantitative
findings were reproduced when an independent gene expres-
sion data set was analysed. Quantifiable differences between
potentially influential functional components (as predicted by
independent single-source analyses and categories) were also found
[2,3,7].
A key conclusion of this research is that only a minority of hubs
(or superhubs) genes are also significantly differentially expressed
in HF. Furthermore, we showed that the observed proportions of
such genes are statistically significant in comparison to the values
expected by chance. The biological relevance of these results can
be summarised as follows. First of all, this study confirms the
weakness of performing functional characterisations of genes based
on gene expression data only. The integrative analysis of gene
expression and functional network data may improve the
predictive ability of future studies. The identification of potential
drug targets in heart failure should include integrative approaches
to estimate significant roles of genes in regulatory processes driving
the emergence of heart failure. Second, this study suggests that
processes relevant to cardiac remodelling and the progression
toward heart failure may be controlled by greater gene expression
modifications of low-connectivity network nodes, and relatively
smaller differential responses in nodes with higher connectivity.
Moreover, hubs and superhubs display a significant diversity of
quantitative co-expression patterns in comparison to peripheral
nodes. This may suggest that gene expression coordination
between hubs (or superhubs) and their interacting partners may
be more subtle that that observed between other genes.
MATERIALS AND METHODS
Microarray data analysis
The microarray data analysed in this study were obtained from the
Gene Expression Omnibus GEO) [13], accession number
GDS2206. This data set, which was derived from a study on
DCM, was composed of 28 samples: 15 and 13 samples from non-
failing hearts and HF patients respectively [2,22]. This data set
was available in Log scale [2], and probes with missing values in
more than 50% of samples, in either group, were excluded. To
quantity differential gene expression, significance analysis of
microarray (SAM) [14] was performed. The algorithm computes
a t statistic, di, representing the score of class differentiation for
gene i. Gene expression differences were considered significant if
False Discovery Rate (FDR) ,0.05 and Folding change .1.2.
In addition, a second microarray data set was used to validate
significant findings (i.e. gene co-expression vs. network patterns)
obtained from the first gene expression data set. This second data
set, also derived from a study on DCM, was obtained from the
GEO, accession number GDS2206, and was composed of 12
samples: 5 samples originated from non-failing hearts and 7
samples were obtained from HF patients [2,22].
A human HF interaction network
A PPI network was assembled by including validated interactions
reported for KHFGs and for proteins encoded by genes included
in the gene expression data sets. This network is offered as a public
resource of the current status of human HF-relevant interactions
(network is provided on request). The list of KHFG was obtained
from the Entrez database [23]. Entrez query was restricted by the
same set of keywords used in King et al. (2003) [3] (i.e. smooth
muscle, endothelial cell, apoptosis, cytokine and adhesion
molecule) and within the context of human HF. PPIs were
retrieved from the HPRD [4]. The HUGO nomenclature
standard was used to define unique id identifiers.
The PPI network was assembled by using a routine written in
JAVA, and its structure was encoded in the SIF format that can be
used by well-known network visualisation tools (e.g. Cytoscape). The
productof this assembly was a network composed of 3412 nodes and
13164interactions.Thenumberofinteractingpartnersrange from1
to more than 100. A colour labelling scheme was used to distinguish
between the types of proteins each node represented. Proteins
encoded by up- and down-regulated genes (as predicted in the gene
expression data) were represented by nodes coloured in green and
red respectively. Proteins encoded by KHFGs were represented by
yellow nodes. Proteins encoded by not significantly differentially
expressed genes were represented by purplenodes. Proteins encoded
by genes whose expression pattern was not present in the data set,
but which encoded relevant interacting partners in the HF network,
were represented by grey nodes.
Nodes in the network were also classified according to the degree
of connectivity, based on a scheme similar to that used in Lu et al.
[10]. Superhubs are represented by nodes with connectivity degree
greater than 100,hubsrefer to nodes with connectivitydegree greater
than 20 and lower than 100, peripheral-A are nodes with connectivity
greater than two and lower than 20; and peripheral-B nodes represent
proteins with one interacting partner only.
Cytoscape v2.4 [24] was used for network visualisation.
Comparing observed vs. expected proportions of
relevant nodes
The statistical significance of the observed proportion (Robs)o f
significantly differentially-expressed genes that were also either
Integrative Bioinformatics
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significance tests. In these analyses the null hypothesis was that the
observed proportion was obtained by chance, i.e. a random null
distribution of genes could have reported proportions as extreme
as the value observed. These statistical significance analyses were
implemented as follows. Based on the results shown above, each
gene was assigned to one of the following labels: ‘‘Significantly
differentially-expressed’’ (SDE) or ‘‘not-SDE’’. This vector of
labels will be referred to as ‘‘expression labels’’. Similarly, each
gene was labelled according to the binary class: ‘‘Superhub-or-
hub’’ or otherwise. This vector of labels will be referred to as
‘‘connectivity labels’’. The first statistical significance assessment
was based on a permutation test as follows. The expression labels
were randomly shuffled to obtain a permutated dataset. Using this
dataset, the proportion (Rper) of SDE that were also either
superhubs or hubs was calculated. This permutation process was
repeated N times, and the number of times, numSigPer, that
Rper$Robs was calculated, with Robs=47/3412. Thus, the statistical
significance of the observed value (probability that the observed
value was obtained by chance) was estimated by P=numSigPer/N,
with N=50000. A second permutation test was conducted in a
similar fashion, but now with only the connectivity labels
randomly shuffled to generate the permutated datasets. In the
third significance assessment test, 506 proteins (i.e. the number of
SDE genes observed) were randomly sampled from the total
population of network nodes (3412 proteins). Based on this sample,
Rrand represents the proportion of genes that were both SDE and
that encoded either hubs or superhubs. This sampling process was
repeated M times, and the number of times, numSigRand, that
Rrand$Robs was calculated, with Robs=47/506. Thus, the proba-
bility of finding Robs at random was estimated by P=numSigRand/
M, with M=50000. All the statistical significance tests reported
P=0, with maximum Rper and Rrand values equal to 20/3412 and
19/506 respectively.
Network vs. gene co-expression analysis
Results from the topological analysis of the network were integrated
with the results obtained from the gene expression data analysis in
ordertoevaluate relationshipsbetweenconnectivityandsignificantly
differentially expressed expression patterns. Furthermore, network
topology was integrated with the DCM expression data to evaluate
gene connectivity versus co-expression levels.
To calculate co-expression levels linked to every node (i) in the
network, node and their interaction partners were mapped into
the gene expression data set. Next, Pearson’s correlation
coefficients between the expression profile of each gene coding
for a node and each gene coding for its interaction partners were
calculated. Correlation value pairs were regarded as significantly
co-expressed if its P-value,0.01. Finally, the co-expression level (cL)o f
a gene (i) was calculated by comparing the number of its
significantly co-expressed interactions (cIPi) against the total
number of its interacting proteins (IPi), i.e. significantly co-
expressed and non-significantly co-expressed interaction partners
(Eq. 1). According to Eq. 1, a co-expression level (cLi) equal to
100% indicates that the gene (i) was significantly co-expressed with
each of the genes encoding its interacting partners in the PPI
network. A co-expression level (cLi) equal to 0% indicates that the
gene (i) was not significantly co-expressed with any of its
interacting partners.
cLi~
cIPi
IPi
ð1Þ
Assuming that a node, i, in the PPI network represents a protein
encoded by a gene, then: i is a node in the network; IPi represents
the set of interacting partners linked to i; cIPi represents the set of
interacting partners significantly co-expressed with i.
To verify that major findings were reproducible, the same
procedures were carried out using a second, independent
microarray data set as described above.
Gene Ontology analysis
Interaction network topology was analysed in the context of the
GO. Cytoscape-BiNGO [25] was applied to detect significantly
over-represented GO biological processes. Benjamini and Hoch-
berg multiple-test corrections adjusted raw P-values at a significant
level,0.05. To increase the level of stringency, GO-IEA terms
were discarded. GO annotations with IEA evidence code refer to
annotations inferred from sequence-based similarity searches,
which have not been reviewed by curators. In addition, using the
GO interaction network, a hierarchical classification scheme was
used to rank over-represented GO biological processes according
to their proximity to the root node of the GO Biological Process
hierarchy. Note that the GO root node is at the top level of the
hierarchy, followed by the Biological Process term and the rest of
the hierarchy terms (e.g., ‘‘developmental process’’ (third level),
‘‘multicellular organismal development’’, on the fourth level). In
this study a higher-level Biological Process is defined as any term above
the fourth level in the GO Biological Process hierarchy. A lower-
level Biological Process is defined as any annotation subsumed by any
term in the fourth level in the GO Biological Process hierarchy.
SUPPORTING INFORMATION
Annex S1 Network proteins and corresponding number of
interacting partners encoded by significantly differentiated genes
Found at: doi:10.1371/journal.pone.0001347.s001 (0.17 MB
XLS)
Annex S2 Significantly over-represented GO biological process-
es.
Found at: doi:10.1371/journal.pone.0001347.s002 (0.09 MB
XLS)
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